CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $189.14M, lower than 95% of all stocks globally
- PositionOperating margin is -44.6%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
267.94BKRW189.14M · vs all stocks (USD)
Revenue (TTM)
4.98BKRW3.52M · vs all stocks (USD)
Profit Margin
-1.58%vs Medical Instruments & Supplies peers
Beta
1.04xvs all stocks
52-Week Change
-41.32%vs all stocks
Market Capitalization
267.94BKRW189.14M · vs all stocks (USD)
Enterprise Value
248.59BKRW175.48M · vs all stocks (USD)
Forward P/E
39.01xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
53.62xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
6.38xvs Medical Instruments & Supplies peers
Enterprise to Revenue
49.91xvs Medical Instruments & Supplies peers
Gross Margin
65.16%vs Medical Instruments & Supplies peers
Profit Margin
-1.58%vs Medical Instruments & Supplies peers
Operating Margin
-44.55%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-2.09%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-0.18%vs Medical Instruments & Supplies peers
Revenue (TTM)
4.98BKRW3.52M · vs all stocks (USD)
Revenue per Share (TTM)
167.37KRWUpdated Jul 9, 2026Quarterly Revenue Growth
-43.40%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
3.02BKRW2.13M · vs all stocks (USD)
EBITDA (TTM)
2.06BKRW1.46M · vs all stocks (USD)
Net Income (TTM)
-78.64MKRW-55.51K · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-38.65%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
-1.04BKRW-732.13K · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-1.33BKRW-940.17K · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
7.03BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
2.56BKRWFY2025 · Dec 31, 2025Gross Profit
4.47BKRWFY2025 · Dec 31, 2025Operating Income
652.26MKRW460.43K · vs all stocks (USD)
Pre-tax Income
831.42MKRWFY2025 · Dec 31, 2025Income Tax Expense
-20.18MKRWFY2025 · Dec 31, 2025Net Income
851.59MKRWFY2025 · Dec 31, 2025EBIT
831.58MKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.06BKRWFY2025 · Dec 31, 2025Research & Development
272.16MKRWFY2025 · Dec 31, 2025Selling, General & Administrative
619.15MKRWFY2025 · Dec 31, 2025Other Operating Expenses
22.38MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
547.96MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
160.00KKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
851.59MKRWFY2025 · Dec 31, 2025Operating Cash Flow
-1.41BKRWFY2025 · Dec 31, 2025Free Cash Flow
-4.67BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
12.98BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
851.59MKRWFY2025 · Dec 31, 2025Other Non-cash Items
-547.80MKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.17BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-545.88MKRWFY2025 · Dec 31, 2025Capital Expenditures
-3.26BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-2.21BKRWFY2025 · Dec 31, 2025Purchase of Investments
-8.83BKRWFY2025 · Dec 31, 2025Sale of Investments
21.71BKRWFY2025 · Dec 31, 2025Other Investing Activity
-10.00KRWFY2025 · Dec 31, 2025Net Investing Cash Flow
9.62BKRWFY2025 · Dec 31, 2025Shares Outstanding
29.48MSharesUpdated Jul 9, 2026Float Shares
17.00MSharesUpdated Jul 9, 2026% Held by Insiders
49.44%vs all stocks
% Held by Institutions
1.05%vs all stocks
Total Cash (MRQ)
19.66BKRW13.88M · vs all stocks (USD)
Total Cash per Share (MRQ)
666.88KRWUpdated Jul 9, 2026Total Debt (MRQ)
3.97MKRW2.80K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0001xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
27.99xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
1.43KKRWUpdated Jul 9, 2026Total Assets
44.94BKRW31.72M · vs all stocks (USD)
Total Current Assets
18.70BKRWFY2025 · Dec 31, 2025Total Liabilities
870.68MKRWFY2025 · Dec 31, 2025Total Non-current Assets
26.24BKRWFY2025 · Dec 31, 2025Total Current Liabilities
870.68MKRWFY2025 · Dec 31, 2025Cash
12.98BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
12.98BKRWFY2025 · Dec 31, 2025Other Short-term Investments
3.00BKRWFY2025 · Dec 31, 2025Accounts Receivable
1.66BKRWFY2025 · Dec 31, 2025Inventory
460.60MKRWFY2025 · Dec 31, 2025Accounts Payable
386.62MKRWFY2025 · Dec 31, 2025Short-term Debt
11.04MKRWFY2025 · Dec 31, 2025Other Current Liabilities
230.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
14.88BKRWFY2025 · Dec 31, 2025Retained Earnings
-14.61BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
44.07BKRW31.11M · vs all stocks (USD)
Treasury Stock
10.52BKRWFY2025 · Dec 31, 202552-Week Low
8.76KKRWUpdated Jul 9, 202652-Week High
16.86KKRWUpdated Jul 9, 202652-Week Change
-41.32%vs all stocks
Beta
1.04xvs all stocks
50-Day MA
10.94KKRWUpdated Jul 9, 2026200-Day MA
12.98KKRWUpdated Jul 9, 2026Avg 10-Day Volume
59.05KSharesUpdated Jul 9, 2026Avg 30-Day Volume
68.90KSharesUpdated Jul 9, 2026Diluted EPS (TTM)
29.00KRWUpdated Jul 9, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -44.6%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: -0.45Industry median: 0.12Industry P5: -0.14Peers compared: 62.00
Current ratio is 27.99×, higher than 95% of its Medical Instruments & Supplies peers (median 2.2×)Significant
Current ratio: 27.99Industry median: 2.20Industry P95: 10.55Peers compared: 62.00
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 62.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.65Profit Margin: -0.02
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 2.23
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $189.14M, lower than 95% of all stocks globallySignificant
Market cap (USD): 189,141,491.996Global P5: 279,010,173.859
Revenue is $3.52M, lower than 95% of all stocks globallySignificant
Revenue (USD): 3,515,980.694Global P5: 32,166,921.735
Coordination data is not yet available for this stock.
Companies that share active interpretations — structural patterns currently present in both stocks.
State Power Rixin Technology Co., Ltd.
4 interpretationsMinimal Tax and Interest DragLiquidity Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedLow-Leverage Liquidity Configuration
Gigavis Co. Ltd.
4 interpretationsMinimal Tax and Interest DragLiquidity Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedLow-Leverage Liquidity Configuration
Hebei Broadcasting & TV Information Network Co. Ltd.
4 interpretationsMinimal Tax and Interest DragLiquidity Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedLow-Leverage Liquidity Configuration